Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Biochemistry|June 23, 2004
The in vitro effects of CRE-decoy oligonucleotides in combination with conventional chemotherapy in colorectal cancer cell linesWai M Liu, Katherine A Scott, Sipra Shahin, et al.
International Journal of Cancer|April 2, 2011
The gene expression profile of unstimulated dendritic cells can be used as a predictor of functionWai M Liu, Jayne L Dennis, Daniel W Fowler, et al.
Anticancer Research|October 28, 2015
Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma CellsKatherine A Scott, Jayne L Dennis, Angus G Dalgleish, et al.
Leukemia & Lymphoma|July 9, 2008
Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approachWai M Liu, Katherine A Scott, Jonathan Shamash, et al.
Oncology Letters|October 23, 2020
The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agentsAndrew M Gravett, Jayne L Dennis, Angus G Dalgleish, et al.
Molecular Biology Reports|July 15, 2009
A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitroWai M Liu, Holger Laux, Jake Y Henry, et al.
Oncology Reports|February 18, 2022
Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy <i>in vitro</i> and <i>in vivo</i>Wai M Liu, Nadine K Hall, Harry S Y Liu, et al.
International Journal of Oncology|June 10, 2016
Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapyWai M Liu, Katherine A Scott, Jayne L Dennis, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2010
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agentsAndrew M Gravett, Wai M Liu, Sanjeev Krishna, et al.
Molecular Cancer Therapeutics|May 30, 2006
Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKTNivedita Sain, Bhavani Krishnan, Michael G Ormerod, et al.
Pageof 3